Metropolis MD: Tech Entrants Won't Replace Science-Led Diagnostics

Metropolis, a diagnostics company, is growing by buying up smaller regional labs.

They're expanding their services, especially in areas with limited access to advanced tests.

They are focused on science-based testing and don't see tech companies as a major threat.

In the last quarter, the company saw strong revenue growth, driven by more patients and specialized tests like those for cancer and genetics.

Metropolis aims to grow by expanding in areas where advanced testing is less accessible.

They focus on quality and building trust with doctors and patients, rather than competing with tech firms.

They aim for sustainable and profitable growth.